AC
CSBR icon

Alexandria Capital’s Champions Oncology CSBR Stock Holding History

Alexandria Capital’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,188
Closed -$6K – 650
2015
Q3 		$6K Buy
+1,188
New +$7.75K ﹤0.01% 457

Other funds holding CSBR

BPI
Battery Partners IX Boston, Massachusetts $22.4M AUM 27.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
SSB
Sandy Spring Bank Olney, Maryland $2.38B AUM 8.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alexandria Capital's CSBR Position: Q4 2015 in Review

Alexandria Capital sold out of Champions Oncology (CSBR) in Q4 2015, closing a stake of 1,188 shares — an estimated $6K sold.

Alexandria Capital first reported a position in CSBR in Q3 2015 and held it in 1 quarter. The position peaked at $6K in Q3 2015. 12 funds tracked by Wall St. Rank hold CSBR as of Q4 2015.

  • Alexandria Capital reported no remaining Champions Oncology position as of Q4 2015 after selling out during the quarter.
  • Alexandria Capital sold 1,188 Champions Oncology shares in Q4 2015, an estimated $6K.
  • Alexandria Capital first reported a position in Champions Oncology in Q3 2015 and held it in 1 quarter.
  • Alexandria Capital's Champions Oncology position peaked at $6K in Q3 2015.
  • 12 funds tracked by Wall St. Rank held Champions Oncology as of Q4 2015.

Based on Alexandria Capital's 13F filing for Q4 2015, filed 12 Feb 2016.